NL189672C - METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A COMPOUND WITH ANTI-TUMOR ACTIVITY - Google Patents
METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A COMPOUND WITH ANTI-TUMOR ACTIVITYInfo
- Publication number
- NL189672C NL189672C NLAANVRAGE7704723,A NL7704723A NL189672C NL 189672 C NL189672 C NL 189672C NL 7704723 A NL7704723 A NL 7704723A NL 189672 C NL189672 C NL 189672C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- tumor activity
- compound
- manufacturing
- pharmaceutical preparation
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title 2
- 238000000034 method Methods 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2619686A DE2619686C2 (en) | 1976-05-04 | 1976-05-04 | Use of a lysolecithin for tumor treatment |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7704723A NL7704723A (en) | 1977-11-08 |
NL189672B NL189672B (en) | 1993-01-18 |
NL189672C true NL189672C (en) | 1993-06-16 |
Family
ID=5977045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7704723,A NL189672C (en) | 1976-05-04 | 1977-04-29 | METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A COMPOUND WITH ANTI-TUMOR ACTIVITY |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS52134027A (en) |
AU (1) | AU517586B2 (en) |
BE (1) | BE854270A (en) |
CA (1) | CA1094455A (en) |
DE (1) | DE2619686C2 (en) |
FR (1) | FR2364656A1 (en) |
GB (1) | GB1583661A (en) |
IE (1) | IE44927B1 (en) |
IL (1) | IL51988A (en) |
IT (1) | IT1071329B (en) |
LU (1) | LU77248A1 (en) |
NL (1) | NL189672C (en) |
NZ (1) | NZ183981A (en) |
SE (1) | SE7705071L (en) |
ZA (1) | ZA772649B (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5396311A (en) * | 1977-01-29 | 1978-08-23 | Toyama Chem Co Ltd | Anti-cander drugs containing lysolecithins |
JPS5528955A (en) * | 1978-08-24 | 1980-02-29 | Toyama Chem Co Ltd | Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same. |
GB2046092B (en) | 1979-03-05 | 1983-11-02 | Toyama Chemical Co Ltd | Pharmaceutical composition containing a lysophospholid and a phospholipid |
US4408052A (en) * | 1980-02-27 | 1983-10-04 | Takeda Chemical Industries, Ltd. | Phospholipid carbamates |
US4551532A (en) * | 1980-05-08 | 1985-11-05 | Takeda Chemical Industries, Ltd. | Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity |
US4444766A (en) * | 1980-10-21 | 1984-04-24 | Boehringer Mannheim Gmbh | Sulfur-containing phospholipid compounds and therapeutic compositions |
JPS5772914A (en) * | 1980-10-22 | 1982-05-07 | Takeda Chem Ind Ltd | Antitumor agent |
EP0061872B1 (en) * | 1981-03-30 | 1985-08-07 | Takeda Chemical Industries, Ltd. | Ethyleneglycol derivatives, their production and use |
DE3127503A1 (en) * | 1981-07-11 | 1983-02-17 | Boehringer Mannheim Gmbh, 6800 Mannheim | NEW PHOSPHOLIPIDS, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
DE3131524A1 (en) * | 1981-08-08 | 1983-02-24 | Röhm GmbH, 6100 Darmstadt | METHOD FOR PRODUCING PHYSIOLOGICAL EFFECTORS |
US4562179A (en) * | 1982-04-19 | 1985-12-31 | Fujisawa Pharmaceutical Co., Ltd. | Phospholipid derivatives, and pharmaceutical composition of the same |
DE3239817A1 (en) * | 1982-07-06 | 1984-01-12 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | NEW GLYCER DERIVATIVES FOR THE SYNTHESIS OF PHOSPHOLIPIDES |
DE3239858A1 (en) * | 1982-07-06 | 1984-01-12 | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | NEW D-MANNITE DERIVATIVES AS STARTING PRODUCTS FOR THE SYNTHESIS OF PHOSPHOLIPIDES |
EP0103877B1 (en) * | 1982-09-21 | 1987-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Phosphate derivatives, process for preparation thereof and pharmaceutical compositions of the same |
US4710579A (en) * | 1984-11-09 | 1987-12-01 | Takeda Chemical Industries, Ltd. | 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof |
US4761404A (en) * | 1985-07-01 | 1988-08-02 | Merck & Co., Inc. | Phospholipid analogs useful as PAF synthesis inhibitors |
EP0209239B1 (en) * | 1985-07-15 | 1989-03-01 | Takeda Chemical Industries, Ltd. | 2-alkanoyloxypropane derivatives, their production and use |
JPS6294A (en) * | 1986-05-09 | 1987-01-06 | Toyama Chem Co Ltd | Novel glycerophosphoric acid derivative and salt and production thereof |
JP2561478B2 (en) * | 1986-07-22 | 1996-12-11 | 武田薬品工業株式会社 | Glycerin derivative |
US5036152A (en) * | 1988-03-10 | 1991-07-30 | Hoechst-Roussel Pharmaceuticals Incorporated | Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids |
US4888328A (en) * | 1988-03-10 | 1989-12-19 | Hoeschst-Roussel Incorporated | Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids |
DE3906952A1 (en) * | 1989-03-04 | 1990-09-06 | Boehringer Mannheim Gmbh | (3- (C (DOWN ARROW)) (DOWN ARROW) (DOWN ARROW) 6 (DOWN ARROW) -C (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) 8 (DOWN ARROW)) ALKANSULFINYL AND 2 SULPHONE -METHOXYMETHYL-PROPYL) - (2-TRIMETHYLAMMONIO-ETHYL) PHOSPHATES, METHOD FOR PRODUCING THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
DE3918082A1 (en) * | 1989-06-02 | 1991-01-24 | Max Planck Gesellschaft | AGENT FOR AUTOIMMUNE DISEASES |
DE3935580C2 (en) * | 1989-10-25 | 1998-05-28 | Medmark Pharma Gmbh | Use of an active pharmaceutical ingredient for the treatment of HIV infections |
WO1992019627A2 (en) * | 1991-04-25 | 1992-11-12 | The University Of British Columbia | Phosphonates and phosphinates as anti-cancer, -inflammatory, -allergy and -myocarditis agents |
ES2034885B1 (en) * | 1991-07-10 | 1994-03-01 | Menarini Lab | PROCEDURE FOR THE PREPARATION OF CETOALQUILGLICEROFOSFOLIPIDOS. |
DK0785773T3 (en) * | 1994-10-14 | 2001-01-29 | Liposome Co Inc | Etherlipid liposomes and their therapeutic use |
US5965159A (en) * | 1996-02-16 | 1999-10-12 | The Liposome Company, Inc. | Etherlipid-containing multiple lipid liposomes |
US6667053B1 (en) | 1996-02-16 | 2003-12-23 | Elan Pharmaceuticals, Inc. | D and L etherlipid stereoisomers and liposomes |
US5942246A (en) * | 1996-02-16 | 1999-08-24 | The Liposome Company, Inc. | Etherlipid containing multiple lipid liposomes |
USRE39042E1 (en) * | 1996-02-16 | 2006-03-28 | The Liposome Company, Inc. | Etherlipid-containing multiple lipid liposomes |
US6007839A (en) * | 1996-02-16 | 1999-12-28 | The Liposome Company, Inc. | Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes |
US6135426A (en) * | 1998-01-07 | 2000-10-24 | Briggs And Stratton Corporation | Priming system for internal combustion engines |
JP5773569B2 (en) * | 2006-11-10 | 2015-09-02 | アルファプトーゼ ゲーエムベーハーAlphaptose Gnbh | Methods for detecting receptor ligand mimetics |
EP2091520B1 (en) | 2006-11-10 | 2012-02-22 | Alphaptose Gmbh | Oral dosage form comprising tri-substituted glycerol compounds |
EP2120873B1 (en) * | 2006-12-20 | 2012-06-27 | Alphaptose Gmbh | Topical dosage form comprising tri-substituted glycerol compounds |
AU2007334775A1 (en) * | 2006-12-20 | 2008-06-26 | Universitatsklinikum Hamburg-Eppendorf | Use of tri-substituted glycerol compounds for the treatment of hematological malignancies |
WO2013156630A1 (en) | 2012-04-20 | 2013-10-24 | Alphaptose Gmbh | S-enantiomer of a tri-substituted glycerol compound |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2009343C3 (en) * | 1970-02-27 | 1980-10-23 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Use of lysolecithins as immunological adjuvants |
DE2009341C3 (en) * | 1970-02-27 | 1979-06-21 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | 3-Octadecyloxy-propanol- (l) -phosphoric acid monocholine ester and process for its preparation |
DE2009342C3 (en) * | 1970-02-27 | 1980-12-18 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Use of glycerol alkyl ether (l) phosphoric acid (3) monocholine esters |
DE2033361C3 (en) * | 1970-07-06 | 1980-02-21 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Acylpropanediol- (13) -phosphoric acid choline ester and process for their preparation |
-
1976
- 1976-05-04 DE DE2619686A patent/DE2619686C2/en not_active Expired
-
1977
- 1977-04-29 NL NLAANVRAGE7704723,A patent/NL189672C/en not_active IP Right Cessation
- 1977-05-02 NZ NZ183981A patent/NZ183981A/en unknown
- 1977-05-02 IL IL51988A patent/IL51988A/en unknown
- 1977-05-02 IT IT23094/77A patent/IT1071329B/en active
- 1977-05-02 SE SE7705071A patent/SE7705071L/en unknown
- 1977-05-03 ZA ZA00772649A patent/ZA772649B/en unknown
- 1977-05-03 GB GB18431/77A patent/GB1583661A/en not_active Expired
- 1977-05-03 CA CA277,458A patent/CA1094455A/en not_active Expired
- 1977-05-03 AU AU24819/77A patent/AU517586B2/en not_active Expired
- 1977-05-03 LU LU77248A patent/LU77248A1/xx unknown
- 1977-05-03 IE IE888/77A patent/IE44927B1/en not_active IP Right Cessation
- 1977-05-04 JP JP5194477A patent/JPS52134027A/en active Granted
- 1977-05-04 FR FR7713522A patent/FR2364656A1/en active Granted
- 1977-05-04 BE BE177280A patent/BE854270A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2619686A1 (en) | 1977-11-24 |
GB1583661A (en) | 1981-01-28 |
IL51988A (en) | 1981-05-20 |
JPS6146455B2 (en) | 1986-10-14 |
ZA772649B (en) | 1978-04-26 |
NZ183981A (en) | 1980-04-28 |
FR2364656A1 (en) | 1978-04-14 |
AU2481977A (en) | 1978-11-09 |
AU517586B2 (en) | 1981-08-13 |
IE44927B1 (en) | 1982-05-19 |
IL51988A0 (en) | 1977-07-31 |
SE7705071L (en) | 1977-11-05 |
NL7704723A (en) | 1977-11-08 |
LU77248A1 (en) | 1977-12-13 |
NL189672B (en) | 1993-01-18 |
JPS52134027A (en) | 1977-11-09 |
CA1094455A (en) | 1981-01-27 |
IT1071329B (en) | 1985-04-02 |
BE854270A (en) | 1977-11-04 |
FR2364656B1 (en) | 1980-03-07 |
DE2619686C2 (en) | 1986-08-07 |
IE44927L (en) | 1977-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL189672C (en) | METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A COMPOUND WITH ANTI-TUMOR ACTIVITY | |
NL7700192A (en) | METHOD OF PREPARING A SWEETMAKING PREPARATION. | |
NL7702083A (en) | ANTIBACTERIAL SYSTEM AS WELL AS A METHOD FOR THE PREPARATION OF FOODS AND FEEDS AND A PHARMACEUTICAL PREPARATION. | |
NL184109C (en) | METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTI-HYPERTENSIVE ACTIVITY; METHOD FOR PREPARING A CYANOGUANIDINE COMPOUND | |
NL178320C (en) | PROCEDURE FOR PREPARING A COMPOUND WITH HISTAMINO-HŸ2 BLOCKING ACTIVITY AND FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THIS COMPOUND. | |
NL7501917A (en) | PHARMACEUTICAL PREPARATION AND HETEROCYCLICAL COMPOUND AND METHOD FOR PREPARING THEM. | |
NL177021B (en) | METHOD FOR PREPARING MEDICINES WITH ANTIBIOTIC ACTIVITY AND MEDICINE COMPOUNDS SUITABLE FOR THAT. | |
NL183724B (en) | METHOD FOR PREPARING C.Q. MANUFACTURE OF A PHARMACEUTICAL PREPARATION WITH ANTI-TUMOR ACTIVITY AND METHOD FOR PREPARING A PLATINACOOSTER DERIVATION COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD | |
NL167683B (en) | METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING N-ACYLPHENYLALANYLAMIDES | |
NL184893C (en) | 1-PHENYL-2-ALKYLAMINOETHANOLS AND METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION, IN PARTICULAR SOURCE-DILATOR ACTION CONTAINING SUCH A COMPOUND | |
NL187349C (en) | PROCESS FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION CONTAINING AN N-ARALKYL-3-PHENYL-2-PROPENENE-1-AMINE AND / OR AN ACID ADDITION SALT THEREOF AND PROCESS FOR PREPARING THESE COMPOUNDS AND THE SAME. | |
NL7703752A (en) | METHOD OF PREPARING A MEDICINAL PRODUCT AGAINST CANCER AND METHOD OF PREPARING AN ACTIVE COMPONENT AS WELL AS THE PREPARED MEDICINAL PRODUCT. | |
NL7703898A (en) | PROCESS FOR PREPARING 2-SUBSTITUTED TRANS-HEXAHYDROPYRIDOINDOLS, PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS USING THEREOF AND PREPARATIONS SO FORMED. | |
NL169591B (en) | PROCEDURE FOR THE PREPARATION OF 2-Ÿ4-(2-FUROYL)-PIPERAZINE-1-YLŸ-4-AMINO-6,7-DIMETHOXYCHINAZOLINE.HYDROCHLORIDE WITH BLOOD PRESSURE-LOWERING ACTIVITY AND A BLOOD PRESSURE-LOWERING MEDICINAL PRODUCT CONTAINING THIS SALT. | |
NL192206B (en) | Process for the preparation of a 13β-alkyl-17O-ethynyl-17β-alkanoyloxy-gon-4-en-3-on-oxime compound, process for the preparation of pharmaceutical preparations with such a compound and the pharmaceutical preparations formed. | |
NL7706888A (en) | METHOD OF PREPARING A PHARMACEUTICAL PREPARATION. | |
NL7704599A (en) | METHOD FOR PREPARING A CEPHALOSPORIN SALT, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND FORMED PHARMACEUTICAL PREPARATION. | |
NL7703011A (en) | PROCESS FOR PREPARING 1-AZACARBOCYCLICAL 2-YLIDEEN DERIVATIVES OF GUANIDINE, PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION USING IT AND SUCH PREPARATION. | |
NL7707849A (en) | METHOD OF PREPARING A PHARMACEUTICAL PREPARATION. | |
NL7705404A (en) | METHOD FOR PREPARING 9- (3-O-ACYL- (BETA) -D- -ARABINOFURANOSYL) ADENINO COMPOUNDS AND 9- (2,3-DI-O-ACYL- (BETA) -D-ARABINOFURANOSYL) ADENINO COMPOUNDS, PROCESS OF PREPARING A PHARMACEUTICAL PREPARATION WITH USE THEREOF AND AN SUCHED PHARMACEUTICAL PREPARATION. | |
NL182283C (en) | METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION | |
NL7708807A (en) | METHOD OF PREPARING A PHARMACEUTICAL PREPARATION. | |
NL166469C (en) | METHOD FOR PREPARING OR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH A BRONCHI-REMOVING ACTIVITY AND SUITABLE ACTIVE SUBSTANCES | |
NL7709639A (en) | METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANTIHERPES VIRUS ACTIVITY. | |
NL7701460A (en) | METHOD FOR PREPARING A PREPARATION FOR THE TREATMENT OF HYPERCHOL ESTER OEMIA. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 970429 |